BioCentury
ARTICLE | Clinical News

NKTR-061 Amikacin Inhale: Phase II data

May 26, 2008 7:00 AM UTC

Preliminary data from a double-blind, placebo-controlled Phase II trial in 73 patients with hospital-acquired, Gram-negative pneumonia, showed that Amikacin Inhale had over 1,000 times the lung exposu...